Hemostemix files for price protection on C$1 million private placement third tranche units offering

• Hemostemix filed a Form 4B seeking price protection for the third tranche of its previously announced non-brokered private placement.
• Offering targets gross proceeds of up to CDN$ 1 million; units include one common share, one-half warrant exercisable at CDN$ 0.12 for 24 months.
• Warrants may face accelerated expiry if the 10-day VWAP reaches at least CDN$ 0.15 following the hold period.
• Expected finder’s fees total about CDN$ 8,000; 80,000 finder warrants issued with a CDN$ 0.06 exercise price.
• Proceeds earmarked for commercialization of ACP-01, manufacturing, Bahamas regulatory filings, working capital; closing remains subject to TSXV acceptance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hemostemix Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609231610NEWSFILECNPR____20260923_315746_1) on September 23, 2026, and is solely responsible for the information contained therein.